Author： Chaubey Asha Parshad Rajinder Koul Surrinder Taneja Subhash Qazi Ghulam
Publisher： Springer Publishing Company
ISSN： 0175-7598
Source： Applied Microbiology and Biotechnology, Vol.73, Iss.3, 2006-12, pp. : 598-606
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Arthrobacter</i> sp. lipase (ABL, MTCC no. 5125) is being recognized as an efficient enzyme for the resolution of drugs and their intermediates. The immobilization of ABL on various matrices for its enantioselectivity, stability, and reusability has been studied. Immobilization by covalent bonding on sepharose and silica afforded a maximum of 380 and 40 IU/g activity, respectively, whereas sol–gel entrapment provided a maximum of 150 IU/g activity in dry powder. The immobilized enzyme displayed excellent stability in the pH range of 4–10 and even at higher temperature, i.e., 50–60°C, compared to free enzyme, which is unstable under extreme conditions. The resolution of racemic auxiliaries like 1-phenyl ethanol and an intermediate of antidepressant drug fluoxetine, i.e., ethyl 3-hydroxy-3-phenylpropanoate alkyl acylates, provided exclusively R</i>-(+) products (∼99% ee, E</i>=646 and 473), compared to cell free extract/whole cells which gave a product with ∼96% ee (E</i>=106 and 150). The repeated use (ten times) of covalently immobilized and entrapped ABL resulted in no loss in activity, thus demonstrating its prospects for commercial applications.
Related content
By Xin Jia-Ying
World Journal of Microbiology and Biotechnology, Vol. 21, Iss. 2, 2005-03 ,pp. :
Access to resources
Recommend
